| BDDE | butanediol-diglycidyl ether |
| CD44 | cluster of differentiation-44 |
| CDMT | 2-chloro-dimethoxy-1,3,5-triazine |
| DFs | dermal fillers |
| DMF | dimethylformamide |
| DMTMM | 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium |
| DMSO | dimethylsulfoxide |
| DVS | divinyl sulfone |
| ECM | extracellular matrix |
| EDC | N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride |
| HA | hyaluronic acid; hyaluronate; hyaluronan |
| HA-CL | urea-crosslinked hyaluronic acid |
| HARE | hyaluronan receptor for endocytosis |
| HAS | hyaluronan synthases |
| H-bonds | hydrogen bonds |
| HYAL | hyaluronidases |
| HMW | high molecular weight |
| GAGs | glycosaminoglycans |
| GRAS | generally regarded as safe |
| LYVE1 | lymphatic vessel endothelial hyaluronan receptor 1 |
| LMW | low molecular weight |
| MW | molecular weight |
| NHS | N-hydroxysuccinimide |
| oHA | oligosaccharides of hyaluronic acid |
| RHAMM | receptor for HA-mediated cell motility |
| ROS | reactive oxygen species |
| TBA | tetrabutylammonium |
| TLRs | Toll-like receptors |